RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Viking Therapeutics EBIT 2024

Viking Therapeutics EBIT

-144.44 M USD

Viking Therapeutics Dividend yield

Ticker

VKTX

ISIN

US92686J1060

WKN

A12GD6

In 2024, Viking Therapeutics's EBIT was -144.44 M USD, a 43.26% increase from the -100.83 M USD EBIT recorded in the previous year.

The Viking Therapeutics EBIT history

YEAREBIT (undefined USD)
2029e-
2028e21.53
2027e-127.99
2026e-198.87
2025e-186.45
2024e-144.44
2023-100.83
2022-70.36
2021-55.68
2020-42.66
2019-32.69
2018-26.16
2017-19.07
2016-13.85
2015-12
2014-23.47
2013-0.1
2012-0.11

Viking Therapeutics Aktienanalyse

What does Viking Therapeutics do?

Viking Therapeutics Inc. is a biotechnology company specializing in the development of drugs for the treatment of metabolic and endocrine disorders. It was founded in 2012 by Brian Lian, Ph.D., and is headquartered in San Diego, California. The company's business model focuses on targeting liver X receptors (LXRs) for the treatment of metabolic disorders. Viking Therapeutics aims to develop treatment options for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as well as osteoporosis and hypothyroidism. Their lead products in development are VK2809 for NAFLD/NASH and VK5211 for osteoporosis. The company has a promising product pipeline and aims to improve the lives of millions of patients. Viking Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Viking Therapeutics's EBIT

Viking Therapeutics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Viking Therapeutics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Viking Therapeutics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Viking Therapeutics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Viking Therapeutics Stock

How much did Viking Therapeutics achieve in EBIT for the current year?

In the current year, Viking Therapeutics has achieved an EBIT of -144.44 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Viking Therapeutics.

How has the EBIT of Viking Therapeutics developed in recent years?

The EBIT of Viking Therapeutics has increased by 43.259% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Viking Therapeutics?

The EBIT of Viking Therapeutics is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Viking Therapeutics pay?

Over the past 12 months, Viking Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Viking Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Viking Therapeutics?

The current dividend yield of Viking Therapeutics is .

When does Viking Therapeutics pay dividends?

Viking Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Viking Therapeutics?

Viking Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Viking Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Viking Therapeutics located?

Viking Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Viking Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Viking Therapeutics from 5/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.

When did Viking Therapeutics pay the last dividend?

The last dividend was paid out on 5/29/2024.

What was the dividend of Viking Therapeutics in the year 2023?

In the year 2023, Viking Therapeutics distributed 0 USD as dividends.

In which currency does Viking Therapeutics pay out the dividend?

The dividends of Viking Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Viking Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Viking Therapeutics

Our stock analysis for Viking Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Viking Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.